Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2019-01, Vol.54 (1), p.138-141
Main Authors: Bittencourt, M. C. B., Mariano, L., Moreira, F., Schmidt-Filho, J., Mendrone-Jr, A., Rocha, V.
Format: Article
Language:English
Subjects:
13/100
631/532/1542
631/67/1990/804
Autografts
Blood donation
Cell Biology
Comparative analysis
Correspondence
Cryopreservation
Disease-Free Survival
Female
Hematology
Hematopoietic stem cells
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Melphalan
Melphalan - administration & dosage
Methods
Middle Aged
Multiple myeloma
Multiple Myeloma - blood
Multiple Myeloma - mortality
Multiple Myeloma - therapy
Patient outcomes
Peripheral blood
Peripheral Blood Stem Cell Transplantation
Peripheral Blood Stem Cells
Public Health
Retrospective Studies
Stem cell transplantation
Stem Cells
Surgery
Survival Rate
Transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-018-0250-1